Edward P. Feener, Chief Scientific Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 7,084 shares at $24.78 ($176K) on 2019-04-17, disclosed to the SEC on 2019-04-18.
Open-market sale of $176k KALV by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.78 | 3,084 | $76K | 43.4% |
| 2 | $24.78 | 3,084 | $76K | 43.4% |
| 3 | $25.39 | 916 | $23K | 13.2% |
| Total | $24.86 avg | 7,084 | $176K | 100% |
| Filing → |
| KALV | SELL | 2024-02-16 | $846K | — | Filing → |
| KALV | SELL | 2024-01-12 | $591K | — | Filing → |
| KALV | SELL | 2024-01-10 | $449K | — | Filing → |